Be Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BE PHARMS, and what generic and branded alternatives to BE PHARMS drugs are available?
BE PHARMS has eleven approved drugs.
Summary for Be Pharms
| US Patents: | 0 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 11 |
Drugs and US Patents for Be Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Be Pharms | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 214646-005 | Jun 6, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Be Pharms | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 214646-004 | Jun 6, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Be Pharms | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 214646-001 | Jun 6, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Be Pharms | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 214646-003 | Jun 6, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
